查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467567

2024-2032 年按产品、流程类型、产品类型、应用、最终用户和地区分類的心室辅助装置市场报告

Ventricular Assist Devices Market Report by Product, Flow Type, Product Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球心室辅助装置市场规模达到 19 亿美元。心臟衰竭的盛行率不断上升、捐赠心臟的供应有限、支持性监管框架和更快的批准、VAD 植入手术技术的改进以及技术进步是推动市场发展的一些关键因素。

心室辅助装置 (VAD) 是一种医疗装置，旨在支持衰弱或衰竭的心臟功能。它们主要用作患者等待心臟移植时的临时措施，或作为不适合移植的患者的长期解决方案。 VAD 透过手术植入，帮助将血液从心室泵送到身体的其他部位。这些设备由通常放置在患者腹部或胸部的帮浦和将帮浦连接到外部电源的传动系统组成。帮浦负责接管心臟的泵血作用，确保血液在全身充分循环。它们可以帮助缓解症状，包括疲劳、呼吸急促和体液滞留。此外，VAD 可以作为移植的桥樑，保持患者稳定并提高他们接受捐赠心臟的机会。因此，VAD 彻底改变了心臟衰竭的治疗方法，为患者提供了更好的生活品质、更高的能量水平和更高的生存率。

心血管疾病（CVD）盛行率的上升是推动市场成长的关键因素之一。除此之外，医疗保健专业人员和患者对 VAD 疗法的益处和可用性的认识不断增强，也有助于市场的扩张。对医疗保健提供者、患者和护理人员进行有关 VAD 治疗心臟衰竭有效性的教育的力度不断加大，导致这些设备的接受度和采用率不断提高。此外，支持性的监管框架和批准也促进了 VAD 的商业化和采用。世界各地的监管机构一直积极参与简化审批流程、确保安全并促进 VAD 技术创新。这种有利的监管环境鼓励製造商投资研发 (R&D) 并引入先进的 VAD。此外，VAD 植入手术技术的进步使得手术更安全、更容易进行。开胸手术或肋下切口等微创手术方法的引入，减少了手术创伤，缩短了恢復时间，并扩大了患者接受 VAD 治疗的资格，从而加速了 VAD 的采用。此外，医疗保健支出的增加，特别是在新兴经济体，也促进了 VAD 市场的成长。其他因素，包括显着的经济成长、改善的医疗基础设施、政府为改善医疗服务而采取的有利倡议，以及患者投资新的心臟衰竭治疗方案的意愿不断增强，预计也将刺激市场成长。

心室辅助装置市场趋势/驱动因素：

心臟衰竭盛行率增加

全球心臟衰竭盛行率的不断上升是推动心室辅助装置市场的重要因素。心臟衰竭病例的增加可归因于人口老化、个人久坐的生活方式、肥胖以及糖尿病和高血压等慢性疾病的增加。心臟衰竭的风险随着年龄的增长而增加，老年人更有可能需要机械循环支持。人口老化，特别是在已开发国家，为 VAD 创造了巨大的患者库，推动了市场的成长。随着心臟衰竭患者数量的持续增长，对 VAD 作为可行治疗选择的需求也在增加。 VAD 为可能对传统疗法没有充分反应的晚期心臟衰竭患者提供了解决方案，提供机械支持并改善他们的生活品质。

捐赠心臟的供应有限

适合移植的供体心臟的稀缺性是推动市场成长的另一个关键因素。心臟移植仍然是治疗末期心臟衰竭的黄金标准。然而，可用的捐赠心臟数量远低于需求。由于 VAD 充当移植的桥樑，可保持患者稳定并提高接受捐赠心臟的机会，因此它们越来越多地被用作不适合移植的患者的长期解决方案。因此，合适的心臟捐赠者的有限性产生了对心臟移植替代品的需求，例如 VAD，预计这将进一步推动预测期内市场的成长。

科技进步的崛起

VAD 技术的快速进步极大地促进了市场的成长。主要参与者的持续研发 (R&D) 努力导致了设备尺寸更小、耐用性提高、控制系统增强以及患者治疗效果更好。这些技术进步将 VAD 的使用范围扩大到了更广泛的患者群体，包括体型较小的患者或患有心臟衰竭的儿童。此外，设备设计和植入技术的进步降低了併发症的风险，提高了设备的可靠性，并提高了患者的舒适度。 VAD 技术的此类创新和改进促进了创新设备的开发，这些设备更有效率、更安全，对医疗保健专业人员和患者都有吸引力，从而支持市场成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球心室辅助装置市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 左心室辅助装置 (LVAD)
    • 市场走向
    • 市场预测
  • 右心室辅助装置 (RVAD)
    • 市场走向
    • 市场预测
  • 双心室辅助装置 (BiVAD)
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按流量类型

  • 脉动流
    • 市场走向
    • 市场预测
  • 非脉动或连续流
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依产品类型

  • 植入式心室辅助装置
    • 市场走向
    • 市场预测
  • 非植入性心室辅助装置
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按应用

  • 移植桥 (BTT) 疗法
    • 市场走向
    • 市场预测
  • 目的地治疗
    • 市场走向
    • 市场预测
  • 通往復苏的桥樑和通往候选的桥樑
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 医院
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格指标

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Abiomed Inc.
    • Berlin Heart GmbH (Syscore GmbH)
    • Bivacor Inc.
    • Calon Cardio
    • Cardiacassist Inc. (LivaNova PLC)
    • CHF Solutions Inc.
    • Jarvik Heart Inc.
    • MAQUET GmbH (Getinge)
    • Medtronic Inc.
    • Syncardia Systems LLC (Versa Capital Management LLC)
    • TandemLife (LivaNova Plc)
    • Terumo Corporation
Product Code: SR112024A2276

The global ventricular assist devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 8.5% during 2024-2032. The growing prevalence of heart failure, limited availability of donor hearts, supportive regulatory framework and faster approvals, improvements in surgical techniques for VAD implantation, and technological advancements represent some of the key factors propelling the market.

Ventricular assist devices (VADs) are medical devices designed to support the functioning of a weakened or failing heart. They are primarily used as a temporary measure while a patient awaits a heart transplant or as a long-term solution for patients who are not eligible for transplantation. VADs are implanted surgically and help pump blood from the heart's ventricles to the rest of the body. These devices consist of a pump, which is typically placed in the patient's abdomen or chest, and a driveline that connects the pump to an external power source. The pump is responsible for taking over the pumping action of the heart, ensuring that blood is adequately circulated throughout the body. They can help relieve symptoms, including fatigue, shortness of breath, and fluid retention. Moreover, VADs can serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart. As a result, VADs have revolutionized the treatment of heart failure, providing patients with improved quality of life, higher energy levels, and increased survival rates.

A rise in the prevalence of cardiovascular diseases (CVDs) represents one of the key factors driving market growth. Besides this, the growing awareness among healthcare professionals and patients about the benefits and availability of VAD therapy is contributing to the market expansion. A surge in efforts to educate healthcare providers, patients, and caregivers about the effectiveness of VADs in managing heart failure has led to increased acceptance and adoption of these devices. In addition, supportive regulatory frameworks and approvals have facilitated the commercialization and adoption of VADs. Regulatory agencies worldwide have been actively involved in streamlining the approval process, ensuring safety, and promoting innovation in VAD technology. Such favorable regulatory environments encourage manufacturers to invest in research and development (R&D) and introduce advanced VADs. Additionally, advancements in surgical techniques for VAD implantation have made the procedure safer and more accessible. The introduction of minimally invasive (MI) surgical approaches, such as thoracotomy or subcostal incisions, has reduced surgical trauma, shortened recovery times, and expanded the eligibility of patients for VAD therapy, which in turn has accelerated the adoption of VADs. Furthermore, the increasing healthcare expenditure, particularly in emerging economies, is contributing to the growth of the VADs market. Other factors, including significant economic growth, improving healthcare infrastructure, favorable government initiatives to enhance healthcare access, and the rising willingness of patients to invest in novel treatment options for heart failure, are also anticipated to stimulate market growth.

Ventricular Assist Devices Market Trends/Drivers:

Increase in the prevalence of heart failure

The growing prevalence of heart failure across the globe is a significant factor driving the market for ventricular assist devices. The rise in heart failure cases can be attributed to the aging population, sedentary lifestyles of individuals, obesity, and an increase in chronic diseases such as diabetes and hypertension. The risk of heart failure rises with age, and older adults are more likely to require mechanical circulatory support. The aging population, especially in developed countries, creates a substantial patient pool for VADs, fueling market growth. As the number of heart failure patients continues to grow, the demand for VADs as a viable treatment option also increases. VADs offer a solution for individuals with advanced heart failure who may not respond adequately to conventional therapies, providing mechanical support and improving their quality of life.

Limited availability of donor hearts

The scarcity of suitable donor hearts for transplantation is another critical factor strengthening the market growth. Heart transplantation remains the gold standard treatment for end-stage heart failure. However, the number of available donor hearts falls significantly short of the demand. Since VADs serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart, they are increasingly being used as a long-term solution for patients who are not eligible for transplantation. As a result, the limited availability of suitable heart donors has generated the need for alternatives to heart transplantation, such as VADs, which is further expected to fuel the growth of the market during the forecast period.

Rise in technological advancements

Rapid advancements in VAD technology have significantly contributed to the growth of the market. Continuous research and development (R&D) efforts by key players have led to smaller device sizes, improved durability, enhanced control systems, and better patient outcomes. These technological advancements have expanded the use of VADs to a broader patient population, including those with smaller body sizes or children with heart failure. Moreover, advancements in device design and implantation techniques have reduced the risk of complications, increased device reliability, and improved patient comfort. Such innovations and improvements in VAD technology have led to the development of innovative devices that are more efficient, safer, and appealing to both healthcare professionals and patients, thereby supporting market growth.

Ventricular Assist Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global ventricular assist devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, flow type, product type, application, and end user.

Breakup by Product:

Left Ventricular Assist Device (LVAD)

Right Ventricular Assist Device (RVAD)

Biventricular Assist Device (BiVAD)

Others

Left ventricular assist device (LVAD) represents the most popular product

The report has provided a detailed breakup and analysis of the market based on the product. This includes left ventricular assist device (LVAD), right ventricular assist device (RVAD), biventricular assist device (BiVAD), and others. According to the report, left ventricular assist device (LVAD) represented the largest segment.

Breakup by Flow Type:

Pulsatile Flow

Non-Pulsatile or Continuous Flow

Non-pulsatile or continuous flow dominates the market

The report has provided a detailed breakup and analysis of the market based on the flow type. This includes pulsatile flow and non-pulsatile or continuous flow. According to the report, non-pulsatile or continuous flow represented the largest segment.

Breakup by Product Type:

Implantable Ventricular Assist Devices

Non-implantable Ventricular Assist Devices

Implantable ventricular assist devices represent the largest product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes implantable ventricular assist devices and non-implantable ventricular assist devices. According to the report, implantable ventricular assist devices represented the largest segment.

Breakup by Application:

Bridge-to-Transplant (BTT) Therapy

Destination Therapy

Bridge to Recovery and Bridge to Candidacy

Bridge-to-transplant (BTT) therapy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes bridge-to-transplant (BTT) therapy, destination therapy, and bridge to recovery and bridge to candidacy. According to the report, bridge-to-transplant (BTT) therapy represented the largest segment.

Breakup by End User:

Ambulatory Surgery Centers

Hospital

Others

Hospital holds the leading position in the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes ambulatory surgery centers, hospital, and others. According to the report, hospital represented the largest segment.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for ventricular assist devices.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Abiomed Inc.

Berlin Heart GmbH (Syscore GmbH)

Bivacor Inc.

Calon Cardio

Cardiacassist Inc. (LivaNova PLC)

CHF Solutions Inc.

Jarvik Heart Inc.

MAQUET GmbH (Getinge)

Medtronic Inc.

Syncardia Systems LLC (Versa Capital Management LLC)

TandemLife (LivaNova PLC)

Terumo Corporation

Key Questions Answered in This Report

  • 1. How big is the global ventricular assist devices market?
  • 2. What is the expected growth rate of the global ventricular assist devices market during 2024-2032?
  • 3. What are the key factors driving the global ventricular assist devices market?
  • 4. What has been the impact of COVID-19 on the global ventricular assist devices market?
  • 5. What is the breakup of the global ventricular assist devices market based on the product?
  • 6. What is the breakup of the global ventricular assist devices market based on the flow type?
  • 7. What is the breakup of the global ventricular assist devices market based on the product type?
  • 8. What is the breakup of the global ventricular assist devices market based on the application?
  • 9. What is the breakup of the global ventricular assist devices market based on the end-user?
  • 10. What are the key regions in the global ventricular assist devices market?
  • 11. Who are the key players/companies in the global ventricular assist devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ventricular Assist Device Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Left Ventricular Assist Device (LVAD)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Right Ventricular Assist Device (RVAD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biventricular Assist Device (BiVAD)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Flow Type

  • 7.1 Pulsatile Flow
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Pulsatile or Continuous Flow
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Product Type

  • 8.1 Implantable Ventricular Assist Devices
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-implantable Ventricular Assist Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Bridge-to-Transplant (BTT) Therapy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Destination Therapy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Bridge to Recovery and Bridge to Candidacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Ambulatory Surgery Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Abiomed Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Berlin Heart GmbH (Syscore GmbH)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Bivacor Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Calon Cardio
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Cardiacassist Inc. (LivaNova PLC)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 CHF Solutions Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Jarvik Heart Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 MAQUET GmbH (Getinge)
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Medtronic Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Syncardia Systems LLC (Versa Capital Management LLC)
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 SWOT Analysis
    • 16.3.12 TandemLife (LivaNova Plc)
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
    • 16.3.13 Terumo Corporation
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Ventricular Assist Device Market: Major Drivers and Challenges
  • Figure 2: Global: Ventricular Assist Device Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Ventricular Assist Device Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Ventricular Assist Device Market: Breakup by Flow Type (in %), 2023
  • Figure 5: Global: Ventricular Assist Device Market: Breakup by Product Type (in %), 2023
  • Figure 6: Global: Ventricular Assist Device Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Ventricular Assist Device Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Ventricular Assist Device Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Ventricular Assist Device Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Ventricular Assist Device (Biventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Ventricular Assist Device (Biventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Ventricular Assist Device (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Ventricular Assist Device (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Ventricular Assist Device (Pulsatile Flow) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Ventricular Assist Device (Pulsatile Flow) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Ventricular Assist Device (Destination Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Ventricular Assist Device (Destination Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Ventricular Assist Device (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Ventricular Assist Device (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Ventricular Assist Device (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Ventricular Assist Device (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia Pacific: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia Pacific: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Ventricular Assist Device Industry: SWOT Analysis
  • Figure 87: Global: Ventricular Assist Device Industry: Value Chain Analysis
  • Figure 88: Global: Ventricular Assist Device Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Ventricular Assist Device Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Ventricular Assist Device Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Ventricular Assist Device Market Forecast: Breakup by Flow Type (in Million US$), 2024-2032
  • Table 4: Global: Ventricular Assist Device Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 5: Global: Ventricular Assist Device Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Ventricular Assist Device Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Ventricular Assist Device Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Ventricular Assist Device Market Structure
  • Table 9: Global: Ventricular Assist Device Market: Key Players